Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer
Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer
批准号:
10471039
负责人:
Avni A Argun
金额:
$100.21万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-17 至 2024-08-31
中文摘要
项目总结/摘要
用于基因突变和个体化非侵入性检测的快速、多路生物传感器
非小细胞肺癌的治疗
迫切需要改进的血液液体活检,以帮助检测循环肿瘤DNA
(ctDNA)。这种检测方法对于指导癌症治疗将是革命性的,因为ctDNA是一种非常特异的癌症。
生物标志物,可以收集非侵入性,从而解决了传统的侵入性组织的挑战,
活组织检查ctDNA的检测是具有挑战性的,因为这些生物标志物以痕量浓度存在,并且是
数量远远超过背景野生型DNA。Giner公司建议开发一种电化学检测
一种快速、灵敏、选择性检测EGFR基因单碱基突变的方法
非小细胞肺癌(NSCLC)对酪氨酸激酶抑制剂(TKI)类药物的敏感性。的
开发的检测方法将适用于多重ctDNA检测,并使用肺癌患者血浆进行验证
样品,并集成到原型微流体装置,从而实现了一个重要的里程碑,
监管评估。这项技术将有助于增加NSCLC患者获得个性化治疗的机会,
更好的治疗结果,并提供比金标准数字PCR检测更具竞争力的优势
在较低的成本、最小化的样品制备要求、增加的多路检测以及更大的
更快的样本到答案的周转时间。
英文摘要
PROJECT SUMMARY/ABSTRACT
Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of
Therapy in Non-Small Cell Lung Cancer
There is an urgent need for improved blood-based liquid biopsies to aid the detection circulating tumor DNA
(ctDNA). Such assays will be revolutionary for guiding cancer treatment because ctDNA is a very specific cancer
biomarker that can be collected non-invasively, thus addressing the challenges of traditional invasive tissue
biopsies. Detection of ctDNA is challenging because these biomarkers exist at trace concentrations and are
vastly outnumbered by background wild type DNA. Giner, Inc. proposes to develop an electrochemical detection
method for rapid, sensitive, and selective detection of single-base mutations in the EGFR gene associated with
sensitivity to the tyrosine kinase inhibitor (TKI) class of drugs in non-small cell lung cancer (NSCLC). The
developed assay will be adapted for multiplexed ctDNA detection, validated with lung cancer patient plasma
samples, and integrated into a prototype microfluidic device, thus achieving a significant milestone toward
regulatory evaluation. This technology will help increase access of personalized therapies to NSCLC patients for
better treatment outcomes, and offer a compelling competitive advantage over gold standard digital PCR tests
in terms of lower cost, minimized sample preparation requirements, increased multiplexed detection, and a much
faster sample-to-answer turnaround time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Field Instrument for Assessment of Arsenic Exposure
-
批准号:10484041
-
项目类别:
-
资助金额:$84.51万
-
财政年份:2023
-
负责人:Avni A Argun
-
依托单位:
Population monitoring of stress markers in underserved communities
-
批准号:10766447
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2023
-
负责人:Avni A Argun
-
依托单位:
Electrochemical Assay to Monitor Anti-TB Antibiotics
-
批准号:10010646
-
项目类别:
-
资助金额:$21.21万
-
财政年份:2021
-
负责人:Avni A Argun
-
依托单位:
At-home Testing of Blood Sodium for Management of Diabetes Insipidus
-
批准号:10395189
-
项目类别:
-
资助金额:$25.96万
-
财政年份:2021
-
负责人:Avni A Argun
-
依托单位:
Rapid Assessment of Illicit Drugs in Wastewater
-
批准号:10576367
-
项目类别:
-
资助金额:$89.31万
-
财政年份:2020
-
负责人:Avni A Argun
-
依托单位:
Rapid Assessment of Illicit Drugs in Wastewater
-
批准号:10397306
-
项目类别:
-
资助金额:$84.91万
-
财政年份:2020
-
负责人:Avni A Argun
-
依托单位:
Rapid, Multiplexed Biosensor for Non-Invasive Detection of Gene Mutations and Personalization of Therapy in Non-Small Cell Lung Cancer
-
批准号:10480889
-
项目类别:
-
资助金额:$99.77万
-
财政年份:2019
-
负责人:Avni A Argun
-
依托单位:
Non-Invasive, Highly Specific Detection of Oxytocin in Biological Fluids
-
批准号:9131542
-
项目类别:
-
资助金额:$22.5万
-
财政年份:2016
-
负责人:Avni A Argun
-
依托单位:
海外基金